Zydus Lifesciences continues focusing on new product launches and expansion within its domestic business to drive future growth. The company is strengthening its specialty product portfolio while exploring opportunities in key international markets.
Its growth strategy includes investments in research, acquisitions, and expanding manufacturing capabilities. The company has also benefited from increasing healthcare demand and a robust product pipeline.
Market observers believe pharmaceutical companies with strong innovation capabilities and diversified product portfolios are well-positioned to capitalize on growing healthcare spending globally.
